Last reviewed · How we verify

NCT02708472

Safety and Efficacy of Synchronized Transcranial Magnetic Stimulation for the Treatment of Generalized Anxiety Disorder

Withdrawn NA Last updated 14 August 2018
What this trial tests

NA trial testing synchronized Transcranial Magnetic Stimulation (sTMS) in Generalized Anxiety Disorder (GAD). Withdrawn.

Timeline
1 April 2016
Primary endpoint
1 April 2017
22 January 2018

Quick facts

Lead sponsorUniversity of Texas Southwestern Medical Center
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Start date1 April 2016
Primary completion1 April 2017
Estimated completion22 January 2018

Drugs / interventions tested

Conditions studied

Sponsor

University of Texas Southwestern Medical Center

Who can join

Adults 18 to 65, any sex, with Generalized Anxiety Disorder (GAD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This clinical trial is an investigator-initiated open label study designed to evaluate the safety and efficacy of sTMS in subjects with Generalized Anxiety Disorder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Generalized Anxiety Disorder (GAD)

Currently open trials in the same condition.

Other University of Texas Southwestern Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02708472.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing